NLS Collaboration

Collaboration - December 20, 2023

Season’s Greetings from Nordic Life Science

We would like to thank our readers, subscribers and collaboration partners for a fruitful 2023, and we wish you all a most wonderful holiday season! 2023 has been – yet another – challenging year, but we have also seen Nordic life science companies and researchers making great progress and announcing positive updates and results. Explore […]

Collaboration - December 20, 2023

NNF commits up to USD 260 million to establish new vaccines initiative

The Novo Nordisk Foundation (NNF) is to establish a state-of-the-art research and vaccine development initiative in collaboration with the University of Copenhagen. Research at the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) will focus initially on TB, influenza and Group A Streptococcus (GAS), which collectively cause more than 2.5 million deaths per year. […]

Collaboration - December 20, 2023

Elekta and Bristol Myers Squibb enter partnership

Elekta has announced a pilot collaboration with Bristol Myers Squibb to develop a digital solution for patients with melanoma. “We are thrilled to collaborate with Bristol Myers Squibb to potentially advance the use of digital health interventions, such as in the treatment of melanoma,” says Anish Patankar, SVP & Head of Business Line Software at […]

Collaboration - December 11, 2023

New Danish alliance with the goal to combat AMR

Pfizer Denmark, Pharmadanmark and the Novo Nordisk Foundation have initiated the alliance and aim to prevent the growing spread of antimicrobial resistance (AMR). “The challenge of antimicrobial resistance cannot be solved by one country alone and requires a global effort. Denmark can play an important role in this by establishing significant initiatives that can inspire […]

Collaboration - December 7, 2023

Camallergy and OnDosis enter strategic collaboration

The partnership is set to transform the way food allergies (including peanut allergy) are treated and will combine Camallergy’s therapies with OnDosis’ Dosage Manager device technology. The drug-device combination aims to address the challenges physicians face in offering oral immunotherapy, making the treatment more accessible for patients, the company states. Oral immunotherapy (OIT) is a […]

Collaboration - November 30, 2023

Highlights from NLSDays 2023

Nordic Life Science Days 2023 offered interesting discussions on business strategies, health data and developments within CNS, a well attended pitching contest, a bubbling atmosphere in beautiful and spacious surroundings, and much more. This is our biggest event so far, with more exhibitors, sponsors and delegates than ever before.” “The tenth anniversary of Nordic Life […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.